Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64 | 210 | 437 | 159 | 65 |
| Marketable Securities | 522 | 1,057 | 667 | 248 | N/A |
| Receivables | 29 | 1,767 | 1,772 | 1,217 | 707 |
| TOTAL | $804 | $3,293 | $2,983 | $2,439 | $1,097 |
| Non-Current Assets | |||||
| PPE Net | 129 | 153 | 175 | 33 | 41 |
| Investments And Advances | 8,328 | 8,716 | 9,170 | 2,280 | 8,082 |
| Intangibles | 0 | 0 | 0 | 2,906 | 0 |
| Other Non-Current Assets | 2,441 | 1,518 | 1,201 | 1,147 | 3,363 |
| TOTAL | $10,897 | $10,387 | $10,545 | $6,366 | $11,487 |
| Total Assets | $11,702 | $13,680 | $13,528 | $8,805 | $12,584 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 60 | 560 | 295 | 60 |
| Accounts payable and accrued liabilities | 1,055 | 949 | 1,319 | 4,628 | 1,576 |
| Other current liabilities | N/A | N/A | N/A | N/A | 80 |
| TOTAL | $1,583 | $2,161 | $2,144 | $8,397 | $1,755 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,190 | 1,189 | 136 | 2,111 | 132 |
| Deferred Revenues | 0 | 0 | 0 | 2,159 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 2,746 | -64 |
| TOTAL | $1,296 | $1,287 | $238 | $2,111 | $68 |
| Total Liabilities | $2,879 | $3,449 | $2,382 | $10,508 | $1,823 |
| Shareholders' Equity | |||||
| Common Shares | 43,800 | 43,800 | 43,683 | 43,308 | 43,608 |
| Retained earnings | -60,044 | -58,637 | -57,358 | -66,719 | -56,955 |
| Other shareholders' equity | 3,129 | 3,130 | 3,027 | 2,876 | 3,219 |
| TOTAL | $8,823 | $10,232 | $11,146 | $1,042 | $10,761 |
| Total Liabilities And Equity | $11,702 | $13,680 | $13,528 | $11,551 | $12,584 |